Sonepcizumab

Tax included
Sonepcizumab (LT 1009) is a fully humanized anti-S1P monoclonal antibody. Sonepcizumab has the potential for the research of metastatic renal cell carcinoma (mRCC).
MedChemExpress 
HY-P99318

Data sheet

Size
Multiple sizes
Reactivity
LPL Receptor
Application
Cancer-programmed cell death
CAS
1031360-18-5